Literature DB >> 32488404

Brain tumor vessels-a barrier for drug delivery.

Casper Hempel1, Kasper B Johnsen2, Serhii Kostrikov2, Petra Hamerlik3, Thomas L Andresen4.   

Abstract

Cancer treatment remains a challenge due to a high level of intra- and intertumoral heterogeneity and the rapid development of chemoresistance. In the brain, this is further hampered by the blood-brain barrier that reduces passive diffusion of drugs to a minimum. Tumors grow invasively and form new blood vessels, also in brain tissue where remodeling of pre-existing vasculature is substantial. The cancer-associated vessels in the brain are considered leaky and thus could facilitate the transport of chemotherapeutic agents. Yet, brain tumors are extremely difficult to treat, and, in this review, we will address how different aspects of the vasculature in brain tumors contribute to this.

Entities:  

Keywords:  Blood vessels; Blood-brain barrier; Brain tumors; Drug delivery; Glioblastoma

Mesh:

Substances:

Year:  2020        PMID: 32488404     DOI: 10.1007/s10555-020-09877-8

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  74 in total

1.  Pericytes regulate the blood-brain barrier.

Authors:  Annika Armulik; Guillem Genové; Maarja Mäe; Maya H Nisancioglu; Elisabet Wallgard; Colin Niaudet; Liqun He; Jenny Norlin; Per Lindblom; Karin Strittmatter; Bengt R Johansson; Christer Betsholtz
Journal:  Nature       Date:  2010-10-13       Impact factor: 49.962

Review 2.  Endothelial Glycocalyx: Shedding Light on Malaria Pathogenesis.

Authors:  Casper Hempel; Erica M Pasini; Jørgen A L Kurtzhals
Journal:  Trends Mol Med       Date:  2016-05-05       Impact factor: 11.951

Review 3.  Extent of Resection in Glioma-A Review of the Cutting Edge.

Authors:  Randy S D'Amico; Zachary K Englander; Peter Canoll; Jeffrey N Bruce
Journal:  World Neurosurg       Date:  2017-04-17       Impact factor: 2.104

4.  Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma.

Authors:  Francesca Pistollato; Sara Abbadi; Elena Rampazzo; Luca Persano; Alessandro Della Puppa; Chiara Frasson; Eva Sarto; Renato Scienza; Domenico D'avella; Giuseppe Basso
Journal:  Stem Cells       Date:  2010-05       Impact factor: 6.277

Review 5.  Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Authors:  Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

6.  The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation.

Authors:  Jana Portnow; Behnam Badie; Mike Chen; An Liu; Suzette Blanchard; Timothy W Synold
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

7.  Brain tumour cells interconnect to a functional and resistant network.

Authors:  Matthias Osswald; Erik Jung; Felix Sahm; Gergely Solecki; Varun Venkataramani; Jonas Blaes; Sophie Weil; Heinz Horstmann; Benedikt Wiestler; Mustafa Syed; Lulu Huang; Miriam Ratliff; Kianush Karimian Jazi; Felix T Kurz; Torsten Schmenger; Dieter Lemke; Miriam Gömmel; Martin Pauli; Yunxiang Liao; Peter Häring; Stefan Pusch; Verena Herl; Christian Steinhäuser; Damir Krunic; Mostafa Jarahian; Hrvoje Miletic; Anna S Berghoff; Oliver Griesbeck; Georgios Kalamakis; Olga Garaschuk; Matthias Preusser; Samuel Weiss; Haikun Liu; Sabine Heiland; Michael Platten; Peter E Huber; Thomas Kuner; Andreas von Deimling; Wolfgang Wick; Frank Winkler
Journal:  Nature       Date:  2015-11-04       Impact factor: 49.962

Review 8.  Development, maintenance and disruption of the blood-brain barrier.

Authors:  Birgit Obermeier; Richard Daneman; Richard M Ransohoff
Journal:  Nat Med       Date:  2013-12-05       Impact factor: 53.440

Review 9.  Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

Authors:  Jann N Sarkaria; Leland S Hu; Ian F Parney; Deanna H Pafundi; Debra H Brinkmann; Nadia N Laack; Caterina Giannini; Terence C Burns; Sani H Kizilbash; Janice K Laramy; Kristin R Swanson; Timothy J Kaufmann; Paul D Brown; Nathalie Y R Agar; Evanthia Galanis; Jan C Buckner; William F Elmquist
Journal:  Neuro Oncol       Date:  2018-01-22       Impact factor: 12.300

10.  Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival.

Authors:  Timothy E Richardson; Seema Patel; Jonathan Serrano; Adwait Amod Sathe; Elena V Daoud; Dwight Oliver; Elizabeth A Maher; Alejandra Madrigales; Bruce E Mickey; Timothy Taxter; George Jour; Charles L White; Jack M Raisanen; Chao Xing; Matija Snuderl; Kimmo J Hatanpaa
Journal:  J Neuropathol Exp Neurol       Date:  2019-06-01       Impact factor: 3.148

View more
  3 in total

1.  The Extension of the LeiCNS-PK3.0 Model in Combination with the "Handshake" Approach to Understand Brain Tumor Pathophysiology.

Authors:  Makoto Hirasawa; Mohammed A A Saleh; Elizabeth C M de Lange
Journal:  Pharm Res       Date:  2022-03-07       Impact factor: 4.580

Review 2.  Obstacles to Glioblastoma Treatment Two Decades after Temozolomide.

Authors:  João Victor Roza Cruz; Carolina Batista; Bernardo de Holanda Afonso; Magna Suzana Alexandre-Moreira; Luiz Gustavo Dubois; Bruno Pontes; Vivaldo Moura Neto; Fabio de Almeida Mendes
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

3.  Optical tissue clearing and machine learning can precisely characterize extravasation and blood vessel architecture in brain tumors.

Authors:  Serhii Kostrikov; Kasper B Johnsen; Thomas H Braunstein; Johann M Gudbergsson; Frederikke P Fliedner; Elisabeth A A Obara; Petra Hamerlik; Anders E Hansen; Andreas Kjaer; Casper Hempel; Thomas L Andresen
Journal:  Commun Biol       Date:  2021-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.